ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Rheumatology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,997Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 151

$531K Total Retail Price of All Prescriptions

Rank: 16 out of 151

454 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
38% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 454 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

13% of this provider’s 454 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

2% of this provider’s 6,237 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $124 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
METHOTREXATE 421 315 1 2
PREDNISONE 374 292 2 1
ALENDRONATE SODIUM 358 269 3 10
SIMVASTATIN 350 287 4 9
HYDROCODONE-ACETAMINOPHEN 274 189 S3 5 7
FUROSEMIDE 243 215 6 20
LISINOPRIL 226 218 7 11
TRAMADOL HCL 212 117 8 4
ALLOPURINOL 202 153 9 5
LEVOTHYROXINE SODIUM 200 196 10 18
HYDROCHLOROTHIAZIDE 192 189 11 19
MELOXICAM 180 114 12 12
GABAPENTIN 179 123 13 6
CYCLOBENZAPRINE HCL 169 43 R 14 14
METOPROLOL TARTRATE 165 158 15 23
OMEPRAZOLE 154 142 16 8
AMLODIPINE BESYLATE 150 138 17 17
ATORVASTATIN CALCIUM 129 110 18 27
ATENOLOL 107 96 19 15
BISOPROLOL-HYDROCHLOROTHIAZIDE 102 102 20 102
DILTIAZEM 24HR ER 97 85 21 74
ATELVIA 88 72 22 105
LOSARTAN POTASSIUM 85 85 23 43
METFORMIN HCL 83 79 24 26
NABUMETONE 82 36 25 21
LYRICA 78 15 26 31
AMITRIPTYLINE HCL 77 32 R 27 32
CELEBREX 75 53 28 16
QUINAPRIL HCL 71 52 29 92
LORAZEPAM 67 67 30 58
SERTRALINE HCL 66 64 31 61
FENOFIBRATE 65 65 32 65
COLCRYS 65 38 32 30
ACTONEL 64 58 34 100
SPIRIVA 64 59 34 76
ZOLPIDEM TARTRATE 61 46 36 45
HYDROXYCHLOROQUINE SULFATE 60 18 37 3
LISINOPRIL-HYDROCHLOROTHIAZIDE 54 54 38 88
LEFLUNOMIDE 51 34 39 24
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 16, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.